Familial partial lipodystrophy, Dunnigan type (FPLD; Mendelian Inheritance in Man #151660), is an autosomal dominant disorder characterized by loss of sc fat from the extremities and trunk since puberty and predisposition to insulin resistance and its complications. However, for lack of recognition of affected men, previous studies could not ascertain any gender differences in phenotypic expression. Therefore, anthropometric variables and prevalence of diabetes mellitus, dyslipidemia, hypertension, and atherosclerotic vascular disease were compared among 17 postpubertal men and 22 women with FPLD from eight pedigrees. All individuals completed a questionnaire, and fasting blood was analyzed for glucose, insulin, and lipoprotein concentrations. Both affected men and women had similar patterns of fat loss. Compared with the affected men, women had higher prevalence of diabetes (18% and 50%, respectively; P ϭ 0.05) and atherosclerotic vascular disease (12% and 45%, respectively; P ϭ 0.04) and had higher serum triglycerides (median values, 2.27 and 4.25 mmol/L, respectively; P ϭ 0.02) and lower high-density lipoprotein cholesterol concentrations (age-adjusted means, 0.94 and 0.70 mmol/L, respectively; P ϭ 0.04). The prevalence of hypertension and fasting serum insulin concentrations were similar. In conclusion, women with FPLD are more severely affected with metabolic complications of insulin resistance than men. These observations raise the possibility that women with generalized and regional obesity may also have more severe metabolic sequelae of insulin resistance. (J Clin
F AMILIAL partial lipodystrophy, Dunnigan variety (FPLD;
Mendelian Inheritance in Man #151660) is a rare autosomal dominant disorder characterized by gradual loss of almost all sc adipose tissue from the extremities commencing at puberty (1) . This results in a characteristic phenotype of "increased muscularity" in the arms and legs. A variable loss of fat also occurs from the trunk. Excess fat may subsequently accumulate in the head and neck and in the intra-abdominal region (2) . Affected subjects are reported to be predisposed to insulin resistance and its metabolic complications, such as impaired glucose tolerance, diabetes mellitus, hypertriglyceridemia, and low levels of high-density lipoprotein (HDL) cholesterol (3) (4) (5) (6) (7) (8) .
The "increased muscularity" phenotype is more readily recognizable in the affected women than in affected men. In fact, early investigators reported only affected women with FPLD and suggested an X-linked dominant inheritance (7) . Although analysis of recent pedigrees clearly reveals an autosomal dominant inheritance (9 -11) , whether there are gender-based differences in the phenotypic expression of genetic defect, particularly pertaining to the pattern of fat loss, severity of insulin resistance and prevalence of metabolic complications, has not been studied. Because the onset of fat loss in FPLD patients occurs at puberty, it is likely that a "steroidresponsive" adipose tissue protein/receptor involved in postpubertal growth and maintenance of sc fat in the extremities may be defective. This further raises the possibility of gender differences in the phenotype. Therefore, physical features, anthropometric data, and the prevalence of metabolic disorders related to insulin resistance (12) , such as dyslipidemia, diabetes mellitus, hypertension, and atherosclerotic vascular disease, were compared among affected and unaffected men and women belonging to eight wellcharacterized families with FPLD.
Patients and Methods Subjects
All eight pedigrees with FPLD, including the five already published (9), were ascertained through referral of an affected female as an index case (Fig. 1) . Informed consent was obtained from all the subjects. Prepubertal subjects were excluded because phenotype could not be determined in them with certainty. The phenotype was classified as affected or unaffected on the basis of history and physical examination, review of their medical records, responses to a written questionnaire, telephone interviews, and inspection of photographs, when available, as detailed earlier (9) . Marked reduction of sc adipose tissue from the extremities and trunk commencing at puberty and extreme muscular appearance were considered the essential criteria for diagnosis. Another important diagnostic criterion was excess adipose tissue accumulation in the face and neck giving a double chin or cushingoid appearance. Unaffected subjects included founders (spouses) as well as nonfounders (siblings).
All eight families were Caucasian and from the United States. All individuals from the F200, F300, F1100, and F1400 pedigrees were evaluated at the General Clinical Research Center of the University of Texas Southwestern Medical Center at Dallas. Information and blood samples on subjects belonging to other pedigrees were obtained by mail.
Methods
Questionnaire. All subjects reported demographic data, date of birth, height, and weight, as well as health history, particularly related to the presence or absence of diabetes mellitus, hypertension, acanthosis nigricans, acute pancreatitis, and atherosclerotic vascular disease including coronary heart disease, stroke, and claudication. The subjects were asked about prior hospitalizations, surgery, smoking, alcohol consumption, and their current medications. Diabetes mellitus was diagnosed on the basis of previous history, use of hypoglycemic medications, or if fasting serum glucose concentration exceeded 7.0 mmol/L (13). Hypertension was diagnosed on self-report or use of antihypertensive medications or if either systolic or diastolic blood pressure exceeded 140 and 90 mm of Hg, respectively (14) .
Blood samples. Blood was collected after a 12-h overnight fast for analysis of serum lipoproteins, insulin, glucose, and a chemistry profile. Blood samples from pedigrees F100, F500, F600, and F700 were sent by overnight mail to the University of Texas Southwestern Medical Center for analysis.
Anthropometric measurements. In the subjects evaluated at Dallas, height and body weight were measured with standard procedures. Skinfold thickness was measured with a Lange caliper (Cambridge Scientific Industries, Cambridge, MD) at five truncal (chest, mid-axillary, abdominal, subscapular, and suprailiac) and four peripheral (biceps, triceps, thigh, and calf) sites on the right side of the body. The mean of three repeat measurements at each site was calculated.
Biochemical analyses
Fasting serum samples were analyzed for cholesterol and triglycerides by an enzymatic method using kits (Roche Molecular Biochemicals, Indianapolis, IN). Serum HDL cholesterol was measured enzymatically after lipoproteins containing apolipoprotein B had been precipitated with phosphotungstic acid (15, 16) . Serum chemistry was measured as a part of the systematic multichannel analysis by a commercial laboratory. Hemoglobin A1C was measured using ion exchange high-performance liquid chromatography (Bio-Rad Laboratories, Inc., Hercules, CA). Serum insulin levels were determined by RIA using commercial kits (Linco Research, Inc., St. Charles, MO).
Statistical Analyses
To compare demographic and anthropometric measurements and metabolic variables in the affected and unaffected men and women, a two-way ANOVA model was used. Status (unaffected, affected) times gender (male, female) interaction was assessed, which reflects differences between unaffected and affected subjects of the same gender and differences between males and females with the same status. A twotailed t test was used to compare affected men and women (the primary comparison) and to compare affected men and women with the unaffected men and women, respectively. Pairwise comparisons are reported without adjustment for multiple testing. For skewed data, nonparametric tests or log transformations were used. Categorical variables were compared using Fisher's exact test. To assess the significance of confounding factors, such as age and body mass index, analysis of covari-FIG. 1. FPLD pedigrees. The pedigrees and each member are numbered for identification. Squares and circles indicate males and females, respectively; /, Deceased subjects; f and F, affected status; Ⅺ and E, unaffected subjects; gray symbols, phenotype uncertain (mostly children); •, a miscarriage. The vertical arrows indicate subjects for whom data are available, whereas the slanting arrows indicate probands from each family.
ance (for serum triglyceride and HDL cholesterol concentrations) or logistic regression models (for prevalence of diabetes mellitus) were used (17) . All analyses were performed using SAS software version 6.12 (SAS Institute, Inc., Cary, NC). A two-sided P value less than 0.05 was the criterion for statistical significance.
Results
The general characteristics of the subjects are given in Table 1 . Affected men were significantly younger that the other three groups. Affected men and women had similar heights as their unaffected counterparts, however, affected women weighed less than unaffected women and had a lower body mass index (P Ͻ 0.005). There were no such differences in body weight or body mass index among the affected and unaffected males.
Skinfold thickness was measured in six women and eight men with FPLD. Compared with normal age-matched men FIG. 2. Skinfold thickness at various anatomic sites in eight men (A) and six women (B) with FPLD. Data are shown as the median (circle) and the 25th and 75th percentile value (whiskers). The bars represent median, 10th and 90th percentile values of skinfold thickness for the normal men and women aged 18 -61 and 18 -55 yr, respectively (18, 19) . Note the considerably reduced peripheral skinfold thickness in both affected men and women. and women (18, 19) , both affected men and women had markedly reduced peripheral skinfold thickness in the extremities (Fig. 2) . All the six affected women but six of the eight affected men had the triceps and thigh skinfold thickness below the 10th percentile for normal women and men, respectively. Although normal values for the calf and biceps skinfold thickness were not available, affected subjects of both genders showed marked reduction in thickness of these skinfolds. The truncal skinfold thickness was variable among the affected subjects. The abdominal and chest skinfolds tended to be thin, but subscapular, axillary, and suprailiac skinfold thickness was normal. There were no statistically significant differences between skinfold thickness of affected men and women. There were no differences in fasting serum glucose and blood hemoglobin A1c concentrations among various groups; however, those on hypoglycemic drugs were excluded (Table 2) . Eight affected women were on hypoglycemic drugs; five on insulin alone and one each on a combination of insulin and glyburide, metformin and glipizide, and metformin and troglitazone. One affected male was on metformin alone. There were no differences in fasting serum insulin concentrations among affected men and women, although the values ranged from normal to high. Overall re- Eight affected females and one affected male were excluded from serum insulin, glucose, and hemoglobin A1c analysis due to drug therapy for diabetes. Thirteen affected females, one affected male, and one unaffected female were excluded from lipids and lipoprotein analyses due to lipid-lowering medications or hormone therapy. One affected female was excluded for uric acid due to gout medication.
a P value refers to status (unaffected, affected) and gender (male, female) interaction, reflecting differences between unaffected and affected subjects of the same gender and between males and females with the same status.
b Log transformed data were used for analyses. sults revealed significantly higher fasting serum insulin levels in affected men compared with unaffected men (P ϭ 0.04), with no significant differences among the two groups of women. Eleven affected women were taking lipid-lowering medications; four were on gemfibrozil alone, four were on a combination of gemfibrozil and statins [pravastatin (1), atorvastatin (2), and lovastatin (1)], one each was on clofibrate, simvastatin, and lovastatin. In addition, one affected woman was on conjugated equine estrogen and one other on medroxy progesterone acetate. One affected male was taking gemfibrozil therapy. These patients were excluded from analysis of lipid and lipoproteins. Fasting serum cholesterol values were not significantly different among the four groups (Table 2) . Fasting serum triglycerides, however, were markedly elevated in affected women compared with affected men (P ϭ 0.02) and unaffected women (P ϭ 0.001) ( Table 2 and Fig. 3 ). Affected men also had higher fasting serum triglyceride concentrations compared with unaffected men (P ϭ 0.04). Affected women tended to have lower serum HDL cholesterol values than affected men but the difference did not achieve statistical significance. However, both affected men and women had significantly lower serum HDL cholesterol concentrations compared with unaffected men and women, respectively (P ϭ 0.02 and 0.001, respectively; Table 2 and Fig. 3 ). Although serum uric acid concentrations were higher in unaffected males compared with unaffected females, this normal gender difference in serum uric acid concentrations was lost in affected subjects. Affected women had higher serum uric acid concentrations than unaffected women (P ϭ 0.005; Table 2 ).
The prevalence of diabetes mellitus was significantly higher among affected women than affected men (50% vs. 18%, respectively; P ϭ 0.049) ( Table 3 and Fig. 4) . Of the 11 affected women with diabetes mellitus, 8 were on hypoglycemic drugs and 3 were on diet therapy. The prevalence of hypertension, however, was similar among affected men and women and also among affected and unaffected subjects (Table 3 and Fig. 4 ). Acanthosis nigricans also showed similar rates of prevalence in affected women and men. Only four affected women had polycystic ovarian disease, five had irregular menstrual periods, and nine had hirsutism. Six of the affected women, but none of the affected men, reported previous episodes of acute pancreatitis. One additional female (F600.32) died of acute pancreatitis at age 29, but for lack of clinical data, she was not included in the analyses. Affected women also had significantly higher prevalence of atherosclerotic vascular disease, including coronary heart disease, stroke, or claudication, compared with affected men (45% vs. 12%, respectively; P ϭ 0.04). Affected men reported higher rates of cigarette smoking and alcohol consumption. Although the affected women were, on average, 11 yr older and had significantly lower body mass indices than the affected men, these covariates were not found to be significant confounders for the prevalence of diabetes mellitus and serum triglyceride concentrations (all P Ͼ 0.2). However, age was a significant covariate for serum HDL cholesterol concentrations (P ϭ 0.006) and a borderline covariate for atherosclerotic vascular disease (P ϭ 0.07). In fact, age-adjusted serum HDL cholesterol concentrations were significantly lower in affected women than in affected men (mean values, 0.70 mmol/L and 0.94 mmol/L, respectively; P ϭ 0.04). After age-adjustment, the trend for higher prevalence of atherosclerotic vascular disease among affected women persisted but was not statistically significant (P ϭ 0.096).
Discussion
Identification of men affected with FPLD had been difficult and all cases reported by early investigators were women (1, 3, 4, 6, 7). Using strict criteria for diagnosis of FPLD phenotype, including clinical features, anthropometry, as well as whole-body magnetic resonance imaging (MRI) studies (2, 9) , a large number of affected men and women from eight pedigrees have been ascertained. Furthermore, we have recently localized the FPLD gene to chromosome 1q21-22 (9) , and genotyping of all these families for markers in that region reveals that all affected men share the disease haplotype in the critical region with the affected women belonging to the same pedigree. Thus, it has become possible for us to investigate gender-based phenotypic differences in patients with FPLD.
The anthropometric data reveal that both affected men and women have similar sc body fat distribution (i.e. marked loss of fat from the extremities, but variable loss from the trunk). Recently, using the MRI, a characteristic and similar pattern of body fat distribution was reported in a male and three females with FPLD (2). The anthropometric data further support the MRI findings. For example, in agreement with the MRI findings of more loss of sc truncal fat anteriorly than posteriorly, the anterior thoracic skinfold was thinner than the posterior, subscapular skinfold in both affected men and women. Furthermore, there were no differences in the skinfold thickness of various sites in affected men and women. Nonetheless, because normal women have more peripheral sc fat than normal men do (18, 19) , the differences in peripheral skinfold thickness among affected and normal women were more marked than those among affected and normal men.
The affected women overall did have more metabolic complications related to insulin resistance than the affected men. They had higher prevalence of diabetes mellitus and atherosclerotic vascular disease, had higher fasting serum triglyceride concentrations, and lower serum HDL cholesterol levels. The prevalence of hypertension, however, was not significantly different among the affected men and women. Serum uric acid concentrations in affected women were similar to those in affected men, which is in sharp contrast to lower serum uric acid concentrations in healthy women compared with healthy men (20) . Thus, all metabolic features associated with insulin resistance were more prevalent in women compared with men with FPLD, except hypertension.
It can be argued that an unusually high proportion of affected women belonging to a pedigree with a mutation causing severe phenotype could have been partly responsible for the results. However, the proportion of affected men and women in all the eight FPLD pedigrees was similar, thus excluding that possibility (Fig. 1) . Furthermore, the possibility of a false positive diagnosis (i.e. misdiagnosing unaffected men as affected, and thereby reducing the prevalence of metabolic complications in men) is negligible because genotyping provided confirmation of the affected status in men.
Clinical data from previous reports (1, 4, 5, 7, 8, (21) (22) (23) (24) (25) ) also support these results but are limited to 25 affected women and 2 affected men [excluding the pedigree reported by Robbins et al. (6) , which is included as F700 pedigree in the current data]. Interestingly, diabetes mellitus, hypertension, and acanthosis nigricans were present in 12 (48%), 8 (32%), and 9 (36%) of the affected women, respectively; these frequencies are similar to those reported in this study (i.e. 50%, 41%, and 33%, respectively). Mean fasting serum triglyceride concentrations among 21 affected women ranged from 0.89 -34.55 mmol/L (median, 3.79). Serum HDL cholesterol concentrations were only reported in two women, both of whom had low values (8) . The two affected men did not have diabetes mellitus, hypertriglyceridemia, hypertension, or acanthosis nigricans (5) .
The underlying mechanisms of the gender differences in phenotypic expression of FPLD still remain to be elucidated. One likely hypothesis is that insulin resistance induced by disorders of adipose tissue is more detrimental in women than in men. Interestingly, Seip and Trygstad (26) , on the basis of their limited experience in four men and two women with congenital generalized lipodystrophy, an autosomal recessive disorder, also suggested that women may be more severely affected than men as far as disturbances in lipid and glucose metabolism are concerned. These observations in monogenic disorders of adipose tissue distribution (i.e. FPLD and congenital generalized lipodystrophy) raise the possibility that women with other types of acquired lipodystrophies, such as acquired generalized lipodystrophy (Lawrence syndrome) and human immunodeficiency virus (HIV)-1, protease inhibitor-induced lipodystrophy may also be more predisposed to metabolic complications than men (26, 27) . Interestingly, FPLD shares some of the phenotypic features with HIV-1 protease inhibitor-induced lipodystrophy in HIV-infected patients, such as extreme loss of sc adipose tissue from the extremities and excess fat deposition in the anterior neck region. Whether, this predisposition of women with adipose tissue disorders to develop more complications of insulin resistance than men pertains to common forms of generalized and regional obesity and type 2 diabetes mellitus remains to be established.
Another possibility could be that women with FPLD are more insulin resistant than are men. However, in our study, fasting serum insulin concentrations, which are surrogate markers for insulin sensitivity, were found to be similar among the affected men and women. Nevertheless, it must be pointed out that 8 of 22 women on hypoglycemic drugs were excluded from these analyses. Thus, future studies involving direct assessment of insulin sensitivity need to be performed in matched groups of men and women with FPLD.
In conclusion, compared with men affected with FPLD, affected women have a similar pattern of loss of sc adipose tissue from the extremities and trunk but are more severely affected with metabolic complications of insulin resistance.
